Among 20 high-risk infants and neonates monitored postoperatively, 11 (55%) developed pulmonary hypertensive crises, resulting in 6 deaths despite aggressive vasodilator therapy.
Observational (n=20)
What are the characteristics and outcomes of pulmonary hypertensive crises following surgery for congenital heart defects in high-risk infants and neonates?
Pulmonary hypertensive crises are common and highly lethal in high-risk infants following congenital heart surgery, requiring rapid aggressive vasodilator therapy and individualized postoperative management.
In this clinical study, 20 high risk infants and neonates were monitored to identify and characterize pulmonary hypertensive crises following surgery for congenital cardiac defects. Monitoring included right ventricular or pulmonary artery pressure catheters and transcutaneous oximetry. Eleven patients also had continuous analog recording of hemodynamic data so that antecedents of crises and the sequence of events following treatment could be reconstructed. Eleven of the 20 patients had one or more crises. Six of these ultimately died whereas 5 patients survived with aggressive vasodilator therapy. Four patients without crises but with episodic pulmonary hypertension benefitted from pulmonary vasodilator therapy to ease weaning from ventilatory support. Typically, each crisis was associated with a stress event. Crises were difficult to ablate if not rapidly treated and multiple crises would often cluster following an initial event. High dose narcotic (fentanyl) analgesia was found to be important in the postoperative management. Tolazoline and oxygen were the most consistently useful vasodilators, but isoproterenol and nitrates also played a role. Five of the children who died were examined post mortem: histologically, there was increased pulmonary arterial muscularization in 2, in none were there changes of fixed pulmonary vascular disease. The postoperative management must be individualized on the basis of monitored responses of pulmonary circulation.
Hopkins et al. (Tue,) conducted a observational in Pulmonary hypertensive crises following surgery for congenital cardiac defects (n=20). Hemodynamic monitoring and vasodilator therapy was evaluated on Pulmonary hypertensive crises. Among 20 high-risk infants and neonates monitored postoperatively, 11 (55%) developed pulmonary hypertensive crises, resulting in 6 deaths despite aggressive vasodilator therapy.